Según el Centro Nacional de Epidemiología Control y Prevención de Enfermedades del Ministerio de Salud del Perú, el último reporte (al 3 de julio del 2019), notifica 653 de SGB, de los cuales 232 son casos confirmados y 421 sospechosos.

Objective: This study analyzed the phenotypic and antifungal resistance profile of fungi isolated from pulmonary infections in critically patients with COVID-19. Materials and methods: Information was obtained on fungal strains isolated at the National Reference Laboratory of Mycology (LRNM) from hospitalized patients with COVID-19. The Fungi were identified by mass spectrometry (MALDI-TOF) and molecular techniques, classifying phenotypes and evaluating antifungal sensitivity according to the Clinical & Laboratory Standards Institute (CLSI). Antifungals such as anidulafungin, micafungin, caspofungin, voriconazole, fluconazole, itraconazole and amphotericin B were tested. Results: In yeasts, Candida albicans was the predominant species (73,5%), followed by Candida tropicalis (19,3%). In filamentous fungi, Aspergillus fumigatus was the most frequent (78,3%), followed by Aspergillus ter...